Annual Cash & Cash Equivalents
N/A
December 1, 2024
Summary
- EW annual cash & cash equivalents is not available.
Performance
EW Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
N/A
December 1, 2024
Summary
- EW quarterly cash and cash equivalents is not available.
Performance
EW Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
EW Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
EW Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Edwards Lifesciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.68 B(+123.6%) |
| Jun 2024 | - | $1.64 B(+34.3%) |
| Mar 2024 | - | $1.22 B(+7.0%) |
| Dec 2023 | $1.14 B(+48.8%) | $1.14 B(-18.9%) |
| Sep 2023 | - | $1.41 B(+35.2%) |
| Jun 2023 | - | $1.04 B(+19.5%) |
| Mar 2023 | - | $872.50 M(+13.5%) |
| Dec 2022 | $769.00 M(-10.9%) | $769.00 M(-38.4%) |
| Sep 2022 | - | $1.25 B(+4.1%) |
| Jun 2022 | - | $1.20 B(+16.2%) |
| Mar 2022 | - | $1.03 B(+19.5%) |
| Dec 2021 | $862.80 M(-27.1%) | $862.80 M(-42.7%) |
| Sep 2021 | - | $1.51 B(+14.8%) |
| Jun 2021 | - | $1.31 B(+11.8%) |
| Mar 2021 | - | $1.17 B(-0.8%) |
| Dec 2020 | $1.18 B(+0.3%) | $1.18 B(+15.5%) |
| Sep 2020 | - | $1.02 B(+13.3%) |
| Jun 2020 | - | $903.50 M(+36.3%) |
| Mar 2020 | - | $662.90 M(-43.8%) |
| Dec 2019 | $1.18 B(+65.1%) | $1.18 B(-0.6%) |
| Sep 2019 | - | $1.19 B(+63.3%) |
| Jun 2019 | - | $726.80 M(+2.5%) |
| Mar 2019 | - | $709.20 M(-0.7%) |
| Dec 2018 | $714.10 M(-12.7%) | $714.10 M(-43.4%) |
| Sep 2018 | - | $1.26 B(+2.8%) |
| Jun 2018 | - | $1.23 B(-0.0%) |
| Mar 2018 | - | $1.23 B(+49.9%) |
| Dec 2017 | $818.30 M(-12.0%) | $818.30 M(+29.8%) |
| Sep 2017 | - | $630.30 M(+24.0%) |
| Jun 2017 | - | $508.20 M(-38.0%) |
| Mar 2017 | - | $819.30 M(-11.9%) |
| Dec 2016 | $930.10 M(+29.5%) | $930.10 M(+44.2%) |
| Sep 2016 | - | $645.00 M(+74.4%) |
| Jun 2016 | - | $369.90 M(-26.2%) |
| Mar 2016 | - | $501.40 M(-30.2%) |
| Dec 2015 | $718.40 M(+9.9%) | $718.40 M(+11.2%) |
| Sep 2015 | - | $646.10 M(+8.1%) |
| Jun 2015 | - | $597.60 M(+30.8%) |
| Mar 2015 | - | $457.00 M(-30.1%) |
| Dec 2014 | $653.80 M(+55.5%) | $653.80 M(+61.8%) |
| Sep 2014 | - | $404.10 M(-19.0%) |
| Jun 2014 | - | $498.60 M(+68.6%) |
| Mar 2014 | - | $295.70 M(-29.7%) |
| Dec 2013 | $420.40 M(+35.2%) | $420.40 M(-10.7%) |
| Sep 2013 | - | $471.00 M(+26.4%) |
| Jun 2013 | - | $372.70 M(-7.2%) |
| Mar 2013 | - | $401.50 M(+29.1%) |
| Dec 2012 | $310.90 M | $310.90 M(+1.7%) |
| Sep 2012 | - | $305.80 M(+0.5%) |
| Jun 2012 | - | $304.30 M(+42.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $213.30 M(+24.6%) |
| Dec 2011 | $171.20 M(-56.8%) | $171.20 M(-62.0%) |
| Sep 2011 | - | $451.10 M(-3.7%) |
| Jun 2011 | - | $468.20 M(+7.9%) |
| Mar 2011 | - | $433.80 M(+9.5%) |
| Dec 2010 | $396.10 M(+18.6%) | $396.10 M(+9.7%) |
| Sep 2010 | - | $361.00 M(+12.7%) |
| Jun 2010 | - | $320.30 M(-0.3%) |
| Mar 2010 | - | $321.20 M(-3.9%) |
| Dec 2009 | $334.10 M(+52.8%) | $334.10 M(+16.2%) |
| Sep 2009 | - | $287.60 M(+57.1%) |
| Jun 2009 | - | $183.10 M(+24.8%) |
| Mar 2009 | - | $146.70 M(-32.9%) |
| Dec 2008 | $218.70 M(+54.2%) | $218.70 M(+8.1%) |
| Sep 2008 | - | $202.40 M(+7.5%) |
| Jun 2008 | - | $188.20 M(+15.5%) |
| Mar 2008 | - | $162.90 M(+14.9%) |
| Dec 2007 | $141.80 M(-22.4%) | $141.80 M(-19.3%) |
| Sep 2007 | - | $175.70 M(+6.5%) |
| Jun 2007 | - | $164.90 M(-8.5%) |
| Mar 2007 | - | $180.20 M(-1.4%) |
| Dec 2006 | $182.80 M(+2.4%) | $182.80 M(+20.8%) |
| Sep 2006 | - | $151.30 M(-9.5%) |
| Jun 2006 | - | $167.10 M(-11.6%) |
| Mar 2006 | - | $189.00 M(+5.8%) |
| Dec 2005 | $178.60 M(+265.2%) | $178.60 M(+103.0%) |
| Sep 2005 | - | $88.00 M(-8.4%) |
| Jun 2005 | - | $96.10 M(+32.4%) |
| Mar 2005 | - | $72.60 M(+48.5%) |
| Dec 2004 | $48.90 M(-20.0%) | $48.90 M(+57.7%) |
| Sep 2004 | - | $31.00 M(-22.5%) |
| Jun 2004 | - | $40.00 M(+5.5%) |
| Mar 2004 | - | $37.90 M(-38.0%) |
| Dec 2003 | $61.10 M(+78.7%) | $61.10 M(+59.5%) |
| Sep 2003 | - | $38.30 M(-24.5%) |
| Jun 2003 | - | $50.70 M(+70.1%) |
| Mar 2003 | - | $29.80 M(-12.9%) |
| Dec 2002 | $34.20 M(-28.3%) | $34.20 M(-12.3%) |
| Sep 2002 | - | $39.00 M(+9.9%) |
| Jun 2002 | - | $35.50 M(+26.8%) |
| Mar 2002 | - | $28.00 M(-41.3%) |
| Dec 2001 | $47.70 M(+70.4%) | $47.70 M(+103.0%) |
| Sep 2001 | - | $23.50 M(-61.9%) |
| Jun 2001 | - | $61.60 M(+244.1%) |
| Mar 2001 | - | $17.90 M(-36.1%) |
| Dec 2000 | $28.00 M(>+9900.0%) | $28.00 M(+112.1%) |
| Sep 2000 | - | $13.20 M(+560.0%) |
| Jun 2000 | - | $2.00 M(-66.7%) |
| Mar 2000 | - | $6.00 M |
| Dec 1999 | $0.00 | - |
FAQ
- What is the all time high annual cash & cash equivalents for Edwards Lifesciences?
- What is the all time high quarterly cash and cash equivalents for Edwards Lifesciences?
What is the all time high annual cash & cash equivalents for Edwards Lifesciences?
Edwards Lifesciences all-time high annual cash & cash equivalents is $1.18 B
What is the all time high quarterly cash and cash equivalents for Edwards Lifesciences?
Edwards Lifesciences all-time high quarterly cash and cash equivalents is $3.68 B